The invention relates to methods for the isolation of AAT from solutionscontaining albumin and AAT using at least two separate metal chelatechromatography steps. The product may be further purified and/or subjected toone or more virus inactivation or reduction steps. The isolated AAT may thenbe formulated for pharmaceutical use.